During the recent session, Medtronic Plc (NYSE:MDT)’s traded shares were 4.08 million, with the beta value of the company hitting 0.81. At the last check today, the stock’s price was $90.12, reflecting an intraday gain of 0.81% or $0.72. The 52-week high for the MDT share is $96.25, that puts it down -6.8 from that peak though still a striking 14.91% gain since the share price plummeted to a 52-week low of $76.68. The company’s market capitalization is $115.47B, and the average intraday trading volume over the past 10 days was 7.64 million shares, and the average trade volume was 7.62 million shares over the past three months.
Medtronic Plc (MDT) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 2.17. MDT has a Sell rating from 1 analyst(s) out of 15 analysts who have looked at this stock. 7 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 7 recommend a Buy rating for it.
Medtronic Plc (NYSE:MDT) trade information
Medtronic Plc (MDT) registered a 0.81% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 0.81% in intraday trading to $90.12, hitting a weekly high. The stock’s 5-day price performance is 1.96%, and it has moved by 2.46% in 30 days. Based on these gigs, the overall price performance for the year is 12.82%. The short interest in Medtronic Plc (NYSE:MDT) is 8.47 million shares and it means that shorts have 1.01 day(s) to cover.
The consensus price target of analysts on Wall Street is $101, which implies an increase of 10.77% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $80 and $165 respectively. As a result, MDT is trading at a discount of -83.09% off the target high and 11.23% off the low.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 0.39%. While earnings are projected to return 1.10% in 2025, the next five years will return 5.55% per annum.
MDT Dividends
Medtronic Plc is due to release its next quarterly earnings on 2025-May-21. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance. Investors should also take the other fundamental and operational aspects into account before investing in the stock. The forward dividend ratio for Medtronic Plc is 2.81, with the dividend yield indicating at 3.12 percent, continuing the trend of increasing dividends in recent years. The average dividend yield of the company for the last 5 years is 2.8%.
Medtronic Plc (NYSE:MDT)’s Major holders
Medtronic Plc insiders own 0.27% of total outstanding shares while institutional holders control 86.84%, with the float percentage being 87.07%. VANGUARD GROUP INC is the largest shareholder of the company, while 2874.0 institutions own stock in it. As of 2024-06-30, the company held over 126.61 million shares (or 9.7895% of all shares), a total value of $9.97 billion in shares.
The next largest institutional holding, with 111.89 million shares, is of BLACKROCK INC.’s that is approximately 8.6517% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $8.81 billion.